SCHEMBL4854857

SCHEMBL4854857

COc1ccc(CN(C)C)c(/C=C/C(=O)c2cc(-c3ccccc3Cl)ccc2OCCN(C)C)c1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.47
SLC6A9 P48067 3/20 0.43
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
MAOB P27338 1/20 0.40
KDM4E B2RXH2 2/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
ATM Q13315 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GAA P10253 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TNFRSF1A P19438 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4845759 1.00 ABCG2 (0.47) ABCG2SLC6A9PDE4APDE4BPDE4C
SCHEMBL4845764 0.91 ABCG2 (0.46) ABCG2SLC6A9PDE4APDE4BPDE4C
SCHEMBL4849331 0.91 SLC6A9 (0.42) ABCG2SLC6A9PDE4APDE4BPDE4C
SCHEMBL6141493 0.91 SLC6A9 (0.42) ABCG2SLC6A9PDE4APDE4BPDE4C
SCHEMBL4848103 0.90 SLC6A9 (0.47) ABCG2SLC6A9KDM4ESMN1; SMN2
SCHEMBL4852269 0.90 SLC6A9 (0.47) ABCG2SLC6A9KDM4ESMN1; SMN2
SCHEMBL4854239 0.88 SLC6A9 (0.46) ABCG2SLC6A9KDM4ELMNAMAPT
SCHEMBL4848047 0.88 SLC6A9 (0.46) ABCG2SLC6A9KDM4ELMNAMAPT
SCHEMBL4854688 0.86 TUBB4A (0.48) ABCG2SLC6A9MAOBMAPTTNFRSF1A
SCHEMBL4851437 0.86 TUBB4A (0.48) ABCG2SLC6A9MAOBMAPTTNFRSF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed